Get the tools used by (smart)2 investors.

Price / LTM FCF for Vyne Therapeutics Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

VYNE: Vyne Therapeutics Inc

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of chronic inflammatory and immune-mediated conditions. Its lead program, repib...

1.70 USD
Price
USD
Fair Value
Upside
1.57 - 4.30
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Vyne Therapeutics Inc's Price / LTM FCF:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024-25.0x-15.0x-5.0x

Performance Summary
  • Vyne Therapeutics's latest twelve months price / ltm fcf is -0.7x
  • Vyne Therapeutics's price / ltm fcf for fiscal years ending December 2020 to 2024 averaged -1.0x.
  • Vyne Therapeutics's operated at median price / ltm fcf of -0.8x from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Vyne Therapeutics's price / ltm fcf peaked in December 2022 at -0.3x.
  • Vyne Therapeutics's price / ltm fcf hit its 5-year low in December 2020 of -2.0x.
  • Vyne Therapeutics's price / ltm fcf decreased in 2023 (-1.3x, +413.8%) and increased in 2020 (-2.0x, -39.1%), 2021 (-0.8x, -61.5%), 2022 (-0.3x, -66.8%), and 2024 (-0.7x, -43.1%).

How does Vyne Therapeutics's Price / LTM FCF benchmark against competitors?

Hide this widget

Metric Usage: Price / LTM FCF

Hide this widget
price_to_fcf_ltm
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Price / LTM FCF in the valuation category include:

  • P/E Ratio (NTM) - The multiple of forecast earnings for the next twelve months that stock investors are willing to pay for one share of the firm.
  • Price / OCF Growth Ratio - A heuristic used to measure the level of revenue growth relative to the Price / OCF multiple.
  • Market Cap / LTM FFO - Indicates the multiple of funds from operations (FFO) that stock investors are willing to pay for one share of the firm.
  • Daily Close (Trading Days Only) - The trading day's adjusted closing price. Only returns data for trading days.
View Full List

Search for metric or datapoint

Price / LTM FCF

Measures the ratio of a stock's price to its levered free cash flow per share.

Definition of Price / LTM FCF

Hide this widget
Measures the ratio of a stock's price to its levered free cash flow per share.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-138.6x-68.6x1.4x138.6x0200400600

The chart above depicts the distribution of price / ltm fcf for companies operating in the Healthcare sector in the Developed economic region. Over 1,970 companies were considered in this analysis, and 1,896 had meaningful values. The average price / ltm fcf of companies in the sector is 0.1x with a standard deviation of 23.5x.

Vyne Therapeutics Inc's Price / LTM FCF of -0.7x ranks in the 54.2% percentile for the sector. The following table provides additional summary stats:

Price / LTM FCF In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,976
Included Constituents1,896
Min-138.0x
Max132.4x
Median-1.1x
Mean0.1x
Standard Deviation23.5x

You can find companies with similar price / ltm fcf using this stock screener.

All rights reserved. Terms Of Use